Published on
Apr 18, 2025
Big Pharma steadying the CGT ship through turbulent waters
Ryan Murray’s keynote presentation at BPI West in San Diego, California in March reflected on the fragile nature of the cell and gene therapy (CGT) space. But despite numerous headwinds – approvals down, investment volatility, job lay-offs, adverse events …
Source:
BioProcess International
-
Neutral
